References
- Andre FE, Booy R, Bock HL, Clemens J, Datta SK, John TJ, Lee BW, Lolekha S, Peltola H, Ruff TA, et al. Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ. 2008;86(2):140–6. doi:10.2471/BLT.07.040089. PMID:18297169.
- Muller CP, Kremer JR, Best JM, Dourado I, Triki H, Reef S. WHO Steering Committee for Measles and Rubella. Reducing global disease burden of measles and rubella: report of the WHO Steering Committee on research related to measles and rubella vaccines and vaccination, 2005. Vaccine. 2007;25(1):1–9. doi:10.1016/j.vaccine.2006.07.039. PMID:17262908.
- Peltola H, Davidkin I, Paunio M, Valle M, Leinikki P, Heinonen OP. Mumps and rubella eliminated from Finland. JAMA. 2000;284(20):2643–7. doi:10.1001/jama.284.20.2643. PMID:11086376.
- Williams WW, Lu P, O'Halloran A, Kim DK, Grohskopf LA, Pilishvili T, Skoff TH, Nelson NP, Harpaz R, Markowitz LE, et al. Surveillance of vaccination coverage among adult populations — United States, 2014. MMWR Surveill Summ. 2016;65(1):1–36. doi:10.15585/mmwr.ss6501a1. PMID:26844596.
- Palachea A, Oriol-Mathieub V, Finoc M, Xydia-Charmantad M. Seasonal influenza vaccine dose distribution in 195 countries (2004–2013): Little progress in estimated global vaccination coverage. Vaccine. 2015;33:5598–5605. doi:10.1016/j.vaccine.2015.08.082. PMID:26368399.
- Public Health England. Seasonal influenza vaccine uptake amongst GP patients in England. Provisional monthly data for 1 September 2017 to 31 January 2018 by NHS England Local Team. [Accessed 2018 March 27]. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/684553/Seasonal_flu_vaccine_uptake_GP_patients_2017_2018_01_September_31_January_Local_Team.pdf.
- Public Health England. Pneumococcal Polysaccharide Vaccine (PPV) coverage report, England, April 2016 to March 2017. Health Protection Report Volume 11 Number 23 [Accessed 2018 March 27]. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/624133/hpr2317_PPV.pdf.
- Public Health England. Herpes zoster (shingles) immunisation programme: September 2016 to August 2017. Report for England. [Accessed 2018 March 27]. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/667636/Annual_shingles_report_2016-2017_.pdf.
- Kuan RK, Janssen R, Heyward W, Bennett S, Nordyke R. Cost-effectiveness of hepatitis B vaccination using HEPLISAV™ in selected adult populations compared to Engerix-B® vaccine. Vaccine. 2013;31(37):4024–32. doi:10.1016/j.vaccine.2013.05.014. PMID: 23707166.
- Macdonald V, Dore GJ, Amin J, van Beek I. Predictors of completion of a hepatitis B vaccination schedule in attendees at a primary health care centre. Sex Health. 2007;4(1):27–30. doi:10.1071/SH06008. PMID:17382034.
- Nelson JC, Bittner RC, Bounds L, Zhao S, Baggs J, Donahue JG, Hambidge SJ, Jacobsen SJ, Klein NP, Naleway AL, et al. Adherence with multiple-dose vaccine schedules among older children, adolescents, and adults: results from a vaccine safety datalink study. Am J Public Health. 2009;99(Suppl.2):S389–97. doi:10.2105/AJPH.2008.151332. PMID:19797753.
- Kohlhammer Y, Schnoor M, Schwatz M, Raspe H, Schäfer T. Determinants of influenza and pneumococcal vaccination in elderly people: a systematic review. Public Health. 2007;121(10):742–51. doi:10.1016/j.puhe.2007.02.011. PMID:17572457.
- CONSORT Group. The CONSORT statement. [Accessed 2017 December 11]. http://www.consort-statement.org/.
- PRISMA. PRISMA Checklist. [Accessed 2017 December 11]. http://prisma-statement.org/PRISMAStatement/Checklist.aspx.